In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Willis Towers Watson (WTW – Research Report), with ...
Fintel reports that on November 13, 2024, TD Cowen downgraded their outlook for Syros Pharmaceuticals (NasdaqGS:SYRS) ...
Shares of Coty (NYSE:COTY) traded lower in pre-market trading on Wednesday after TD Cowen analysts downgraded the beauty ...
TD Cowen downgraded Coty (COTY) to Hold from Buy with a price target of $8.50, down from $11. While Coty has a unique business and platform ...
We recently compiled a list of the 13 AI News You Probably Missed. In this article, we are going to take a look at where ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 0.33% of ...
Chris Krueger, MD, TD Cowen Washington Research Group, shares his thoughts on Trump’s policies when he takes office again in ...
We recently compiled a list of the 10 AI News and Ratings Investors Should Not Miss. In this article, we are going to take a ...
Shares of investment management firm Onex rose Monday after TD Cowen upgraded the company's outlook on the back of its strong portfolio performance and fundraising. Shares recently traded 6.1% higher ...
Onex Corp. shares are climbing after the Canadian investment firm shed its only neutral rating, with TD Cowen upgrading the ...
TD Cowen analyst Ken Cacciatore raised the firm’s price target on Biohaven (BHVN) to $75 from $55 and keeps a Buy rating on the shares. The firm said they expect Phase III data for T-alfa in SMA ...